{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:54:48Z","timestamp":1787684088638,"version":"build-2784847793"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"am","delay-in-days":318,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17ek0109249"],"award-info":[{"award-number":["JP17ek0109249"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["29-3"],"award-info":[{"award-number":["29-3"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.nmd.2021.01.005","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T14:00:04Z","timestamp":1610632804000},"page":"194-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Urinary titin as a biomarker in Fukuyama congenital muscular dystrophy"],"prefix":"10.1016","volume":"31","author":[{"given":"Takatoshi","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Awano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minobu","family":"Shichiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terumi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Shirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Ishigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2021.01.005_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0387-7604(81)80002-2","article-title":"Congenital progressive muscular dystrophy of the Fukuyama type \u2013 clinical, genetic and pathological considerations","volume":"3","author":"Fukuyama","year":"1981","journal-title":"Brain Dev"},{"key":"10.1016\/j.nmd.2021.01.005_bib0002","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/28653","article-title":"An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy","volume":"394","author":"Kobayashi","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2021.01.005_bib0003","doi-asserted-by":"crossref","first-page":"39375","DOI":"10.1038\/srep39375","article-title":"Establishment of a highly sensitive sandwich ELISA for the N-terminal fragment of titin in urine","volume":"6","author":"Maruyama","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.nmd.2021.01.005_bib0004","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev-physiol-021317-121234","article-title":"Titin gene and protein functions in passive and active muscle","volume":"80","author":"Linke","year":"2018","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.nmd.2021.01.005_bib0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cca.2017.11.024","article-title":"Diagnostic and clinical significance of the titin fragment in urine of Duchenne muscular dystrophy patients","volume":"476","author":"Awano","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.nmd.2021.01.005_bib0006","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.nmd.2016.09.014","article-title":"The gross motor function measure is valid for Fukuyama congenital muscular dystrophy","volume":"27","author":"Sato","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.01.005_bib0007","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/(SICI)1096-8628(20000529)92:3<184::AID-AJMG5>3.0.CO;2-N","article-title":"Haplotype-phenotype correlation in Fukuyama congenital muscular dystrophy","volume":"92","author":"Saito","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.nmd.2021.01.005_bib0008","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0140-6736(19)32910-1","article-title":"Muscular dystrophies","volume":"394","author":"Mercuri","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.nmd.2021.01.005_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1357-2725(99)00095-3","article-title":"Calpains and muscular dystrophies","volume":"32","author":"Tidball","year":"2000","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.nmd.2021.01.005_bib0010","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature00837","article-title":"Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies","volume":"418","author":"Michele","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2021.01.005_bib0011","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1152\/japplphysiol.00420.2013","article-title":"Acute change of titin at mid-sarcomere remains despite 8 wk of plyometric training","volume":"116","author":"Macaluso","year":"2014","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.nmd.2021.01.005_bib0012","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1085\/jgp.200709888","article-title":"Disuse-induced preferential loss of the giant protein titin depresses muscle performance via abnormal sarcomeric organization","volume":"131","author":"Udaka","year":"2008","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.nmd.2021.01.005_bib0013","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.braindev.2011.06.002","article-title":"Severe muscle damage following viral infection in patients with Fukuyama congenital muscular dystrophy","volume":"34","author":"Murakami","year":"2012","journal-title":"Brain Dev"},{"key":"10.1016\/j.nmd.2021.01.005_bib0014","doi-asserted-by":"crossref","first-page":"U127","DOI":"10.1038\/nature10456","article-title":"Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy","volume":"478","author":"Taniguchi-Ikeda","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2021.01.005_bib0015","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.nmd.2017.05.009","article-title":"Dramatic elevation in urinary amino terminal titin fragment excretion quantified by immunoassay in Duchenne muscular dystrophy patients and in dystrophin deficient rodents","volume":"27","author":"Robertson","year":"2017","journal-title":"Neuromuscul Disord"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621000067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621000067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:22:22Z","timestamp":1778570542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896621000067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0960896621000067"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2021.01.005","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary titin as a biomarker in Fukuyama congenital muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2021.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}